Via Scientific develops Via Foundry, a multi-omics platform that leverages AI to analyze large-scale, complex, and dynamic biological data to uncover novel associations, biomarkers, and pathways. Originally developed in the Bioinformatics Core at the University of Massachusetts Chan Medical School, the platform supports pharmaceutical companies, biotechs, and academic researchers. Via Foundry incorporates a library of hundreds of bioinformatic processes, pipelines, and AI models to enable reproducible discovery. The company plans to use the newly raised funds to accelerate go-to-market activities, extend its existing library, and expand its technology and scientific teams. Via Scientific is led by CEO Jim Crowley and CTO Alper Kucukural and is headquartered in Boston, MA. Financially, the company raised $5M in Seed funding from a syndicate led by G20 Ventures and Innospark Ventures.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2024